Clinical Trials Browser

Phase 2 × Interventional × Hepatocellular Carcinoma Resectable × Clear all

NCT07363356 2026-01-23

Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Hepatocellular Carcinoma Resectable